FDA inspection

Trends

FDA Increased For-Cause Inspections Almost 250% in 2025

Conference Spotlight

A Glimpse into the Thought Processes of an FDA Expert Investigator

Conference Spotlight

FDA on the Evolution of Biologics Inspections: Part III

Conference Spotlight

Who Decides if my FDA Inspection is Classified OAI?

Where is My EIR?

Conference Spotlight

FDA on Compliance Issues in Pharma

Redica Responds: How Many GMP Inspections Have Resulted in a 483?

Redica Responds: Top Quality Systems Issues at Medical Device Sites

Conference Spotlight

From Data Integrity to Data Culture

A Short Guide to GMP Process Validation

What Can Trigger a CAPA?

What is GMP Compliance? A Complete 2025 Guide

Conference Spotlight

Perforated Tables in Cleanrooms Draw FDA Attention